United States Intravenous-to-Subcutaneous Drugs Market Report 2021

August 2016 | 107 pages | ID: UD8B321333EEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Intravenous-to-Subcutaneous Drugs

Revenue, means the sales value of Intravenous-to-Subcutaneous Drugs

This report studies sales (consumption) of Intravenous-to-Subcutaneous Drugs in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Amgen
• AstraZeneca
• Baxter
• Britannia
• Capricor
• CSL Behring
• GlaxoSmithKline
• Grifols
• Ferring
• Janssen
• NeuroDerm
• Octapharma
• Roche
• Rhythm Metabolic
• scPharmceuticals
• SteadyMed
• Takeda
• United Therapeutics
• UCB
• US Worldmeds

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Antibiotics
• Antibodies
• Anticoagulants
• Antiemetics
• Blood Factors
• Diuretics
• Hormones
• Plasma-derived Immune Inhibitors
• Recombinant Immunotherapeutics
• Vasodilators

Split by applications, this report focuses on sales, market share and growth rate of Intravenous-to-Subcutaneous Drugs in each application, can be divided into

• Medical care
• Hospital
• Application 3

Contents

United States Intravenous-to-Subcutaneous Drugs Market Report 2021

1 INTRAVENOUS-TO-SUBCUTANEOUS DRUGS OVERVIEW

1.1 Product Overview and Scope of Intravenous-to-Subcutaneous Drugs
1.2 Classification of Intravenous-to-Subcutaneous Drugs
  1.2.1 Antibiotics
  1.2.2 Antibodies
  1.2.3 Anticoagulants
  1.2.4 Antiemetics
  1.2.5 Blood Factors
  1.2.6 Diuretics
  1.2.7 Hormones
  1.2.8 Plasma-derived Immune Inhibitors
  1.2.9 Recombinant Immunotherapeutics
  1.2.10 Vasodilators
1.3 Applications of Intravenous-to-Subcutaneous Drugs
  1.3.1 Medical care
  1.3.2 Hospital
  1.3.3 Application
1.4 USA Market Size (Value and Volume) of Intravenous-to-Subcutaneous Drugs (2011-2021)
  1.4.1 USA Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
  1.4.2 USA Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
  1.4.3 USA Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)

2 USA INTRAVENOUS-TO-SUBCUTANEOUS DRUGS COMPETITION BY MANUFACTURERS

2.1 USA Intravenous-to-Subcutaneous Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Intravenous-to-Subcutaneous Drugs Revenue and Share by Manufactures (2015 and 2016)

3 USA INTRAVENOUS-TO-SUBCUTANEOUS DRUGS (VOLUME AND VALUE) BY TYPE

3.1 USA Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type (2011-2021)
3.2 USA Intravenous-to-Subcutaneous Drugs Revenue and Market Share by Type (2011-2021)

4 USA INTRAVENOUS-TO-SUBCUTANEOUS DRUGS (VOLUME) BY APPLICATION

5 USA INTRAVENOUS-TO-SUBCUTANEOUS DRUGS MANUFACTURERS ANALYSIS

5.1 Amgen
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    5.1.2.1 Antibiotics
    5.1.2.2 Antibodies
  5.1.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Amgen (2015 and 2016)
5.2 AstraZeneca
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Antibiotics
    5.2.2.2 Antibodies
  5.2.3 Pharmaceuticals Sales, Revenue, Price of AstraZeneca (2015 and 2016)
5.3 Baxter
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Baxter Product Type and Technology
    5.3.2.1 Antibiotics
    5.3.2.2 Antibodies
  5.3.3 Baxter Sales, Revenue, Price of Baxter (2015 and 2016)
5.4 Britannia
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Ferring Product Type and Technology
    5.4.2.1 Antibiotics
    5.4.2.2 Antibodies
  5.4.3 Britannia Sales, Revenue, Price of Britannia (2015 and 2016)
5.5 Capricor
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Capricor Product Type and Technology
    5.5.2.1 Antibiotics
    5.5.2.2 Antibodies
  5.5.3 Capricor Sales, Revenue, Price of Capricor (2015 and 2016)
5.6 CSL Behring
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 CSL Behring Product Type and Technology
    5.6.2.1 Antibiotics
    5.6.2.2 Antibodies
  5.6.3 CSL Behring Sales, Revenue, Price of CSL Behring (2015 and 2016)
5.7 GlaxoSmithKline
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 GlaxoSmithKline Product Type and Technology
    5.7.2.1 Antibiotics
    5.7.2.2 Antibodies
  5.7.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
5.8 Grifols
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 Grifols Product Type and Technology
    5.8.2.1 Antibiotics
    5.8.2.2 Antibodies
  5.8.3 Grifols Sales, Revenue, Price of Grifols (2015 and 2016)
5.9 Ferring
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Ferring Product Type and Technology
    5.9.2.1 Antibiotics
    5.9.2.2 Antibodies
  5.9.3 Ferring Sales, Revenue, Price of Ferring (2015 and 2016)
5.10 Janssen
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Janssen Product Type and Technology
    5.10.2.1 Antibiotics
    5.10.2.2 Antibodies
  5.10.3 Janssen Sales, Revenue, Price of Janssen (2015 and 2016)
5.11 NeuroDerm
5.12 Octapharma
5.13 Roche
5.14 Rhythm Metabolic
5.15 scPharmceuticals
5.16 SteadyMed
5.17 Takeda
5.18 United Therapeutics
5.19 UCB
5.20 US Worldmeds

6 INTRAVENOUS-TO-SUBCUTANEOUS DRUGS TECHNOLOGY AND DEVELOPMENT TREND

6.1 Intravenous-to-Subcutaneous Drugs Technology Analysis
6.2 Intravenous-to-Subcutaneous Drugs Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Intravenous-to-Subcutaneous Drugs
Table Classification of Intravenous-to-Subcutaneous Drugs
Figure USA Sales Market Share of Intravenous-to-Subcutaneous Drugs by Type in 2015
Figure Antibiotics Picture
Figure Antibodies Picture
Figure Anticoagulants Picture
Figure Antiemetics Picture
Figure Blood Factors Picture
Figure Diuretics Picture
Figure Hormones Picture
Figure Plasma-derived Immune Inhibitors Picture
Figure Recombinant Immunotherapeutics Picture
Figure Vasodilators Picture
Table Applications of Intravenous-to-Subcutaneous Drugs
Figure USA Sales Market Share of Intravenous-to-Subcutaneous Drugs by Application in 2015
Figure Medical care Examples
Figure Hospital Examples
Table USA Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
Figure USA Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
Figure USA Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Table USA Intravenous-to-Subcutaneous Drugs Sales of Key Manufacturers (2015 and 2016)
Table USA Intravenous-to-Subcutaneous Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Intravenous-to-Subcutaneous Drugs Sales Share by Manufacturers
Figure 2016 Intravenous-to-Subcutaneous Drugs Sales Share by Manufacturers
Table USA Intravenous-to-Subcutaneous Drugs Revenue by Manufacturers (2015 and 2016)
Table USA Intravenous-to-Subcutaneous Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Intravenous-to-Subcutaneous Drugs Revenue Share by Manufacturers
Table 2016 USA Intravenous-to-Subcutaneous Drugs Revenue Share by Manufacturers
Table USA Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type (2011-2021)
Table USA Intravenous-to-Subcutaneous Drugs Sales Share by Type (2011-2021)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drugs by Type (2011-2021)
Figure USA Intravenous-to-Subcutaneous Drugs Sales Growth Rate by Type (2011-2021)
Table USA Intravenous-to-Subcutaneous Drugs Revenue and Market Share by Type (2011-2021)
Table USA Intravenous-to-Subcutaneous Drugs Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Intravenous-to-Subcutaneous Drugs by Type (2011-2021)
Figure USA Intravenous-to-Subcutaneous Drugs Revenue Growth Rate by Type (2011-2021)
Table USA Intravenous-to-Subcutaneous Drugs Sales and Market Share by Application (2011-2021)
Table USA Intravenous-to-Subcutaneous Drugs Sales Share by Application (2011-2021)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drugs by Application (2011-2021)
Figure USA Intravenous-to-Subcutaneous Drugs Sales Growth Rate by Application (2011-2021)
Table Amgen Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Amgen (2015 and 2016)
Table AstraZeneca Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Baxter Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Baxter (2015 and 2016)
Table Britannia Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Britannia (2015 and 2016)
Table Capricor Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Capricor (2015 and 2016)
Table CSL Behring Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of CSL Behring (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Grifols Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Grifols (2015 and 2016)
Table Ferring Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Ferring (2015 and 2016)
Table Janssen Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Janssen (2015 and 2016)
Table NeuroDerm Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of NeuroDerm (2015 and 2016)
Table Octapharma Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Octapharma (2015 and 2016)
Table Roche Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Roche (2015 and 2016)
Table Rhythm Metabolic Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Rhythm Metabolic (2015 and 2016)
Table scPharmceuticals Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of scPharmceuticals (2015 and 2016)
Table SteadyMed Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of SteadyMed (2015 and 2016)
Table Takeda Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Takeda (2015 and 2016)
Table United Therapeutics Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of United Therapeutics (2015 and 2016)
Table UCB Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of UCB (2015 and 2016)
Table US Worldmeds Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of US Worldmeds (2015 and 2016)